Our Service Portfolio
Consulting & Strategy
In the area of Healthcare & Pharma Consulting and Strategy, the consultants of ALEA Life Science put their international experience and analytical methods as well as their industry-specific expertise at the service of their clients in the development of promising strategies. This may involve market or benchmarking analyses as well as concepts for successful market entry in countries of the EU, but also Ukraine, China and South Korea.
Experience, methods and networks in the fields of pharmaceuticals, healthcare and private equity
The founding partners of ALEA Life Science have successfully developed and implemented turnaround and business development strategies in the DACH region, Eastern Europe and other countries, both in consulting and in operational responsibility. Therefore, in addition to experience, they also have the necessary information sources and networks to create meaningful analyses and develop promising concepts - whether for strongly focused topics such as the optimization of sales structures or for complex tasks such as the development of turnaround strategies or due diligence in preparation for a company sale or acquisition.
The market players for whom ALEA Life Science provides strategy development and consulting services include companies from the healthcare, pharmaceutical, biotech and medical technology sectors as well as nationally and internationally active investors from the private equity sector.
Partnering & Licensing
The international competence in the field of pharmaceuticals and healthcare as well as the practical experience of the founding partners of ALEA Life Science with projects in Germany, Austria and Switzerland as well as in various countries in Eastern Europe and in China and India form the solid basis for the offer of ALEA Life Science when it comes to partnering and licensing topics.
Successful cross-border projects and international network as a basis.
The range of cross-border cooperations is large and contains concrete growth potential for many companies. ALEA Life Science's services in this area range from the search for suitable production and distribution partners to the initiation of strategic cooperations and participations to support in the conclusion of promising licensing agreements.
Decisive for success are the selection of the right partners, the proper drafting of contracts in accordance with the respective national customs, as well as the reliable implementation of the agreements. All this is guaranteed by a cooperation with ALEA Life Science.
​
Mergers & Acquisitions
Successful work in the field of mergers and acquisitions requires not only in-depth knowledge of the pharmaceutical and healthcare industries, but also experience in working with investors from family offices and private equity companies. The dynamic markets of the healthcare industry are characterized by international corporations, owner-managed traditional companies and fast-growing start-ups. For investors, this means encountering a wide variety of corporate cultures and new players. The potential of innovative products and services is often difficult to assess, and their value can usually only be determined if the markets and competitive environment are well known.
Familiar with the industry and with PE
The founding partners of ALEA Life Science are intimately familiar with due diligences in the pharmaceutical, healthcare, biotech and medical technology sectors because they have both the industry know-how and the knowledge of M&A as well as contacts to investors in Germany and abroad through a large number of realized due diligence processes. ALEA Life Science can act for both buyers and sellers of companies or company shares. Whether private equity company or business angel, multinational conglomerate or owner-managed niche champion - the preparation of successful M&A transactions is part of ALEA Life Science's core business.
